MLNT
Melinta Therapeutics, Inc.

Market cap $407.49M
Enterprise value $116.58M
Employees 45
Revenue $29.6M
EBITDA -$54.6M
Income -$85M
EPS -70.56
P/E N/A
Forward P/E -2.39
EV/EBITDA -2.13
PEG N/A
Earnings date N/A
Volume 99.9k / 156k
Relative vol. 0.64 ×
Profit margin -210.97%
Oper. margin -185.97%
Gross margin 60.80%
Sales Q/Q -78.39%
Sales Y/Y 22.72%
Est. EPS Q/Q N/A
Beta 1.11
Mean Recomm. 2.60
IPO year 2012
Country United States
RSI 32.11
Range $12.75 – $13.40
52 weeks $10.25 – $24.25
SMA 50 $15 +11.72%
SMA 200 $15 +14.43%
1 year target $18 +38.46%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger